Annual Operating Expenses
$11.30 M
-$3.46 M-23.41%
December 31, 2023
Summary
- As of February 24, 2025, QLGN annual total operating expenses is $11.30 million, with the most recent change of -$3.46 million (-23.41%) on December 31, 2023.
- During the last 3 years, QLGN annual operating expenses has risen by +$575.60 thousand (+5.36%).
- QLGN annual operating expenses is now -52.87% below its all-time high of $23.98 million, reached on December 31, 2021.
Performance
QLGN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$1.27 M
-$472.20 K-27.13%
September 30, 2024
Summary
- As of February 24, 2025, QLGN quarterly total operating expenses is $1.27 million, with the most recent change of -$472.20 thousand (-27.13%) on September 30, 2024.
- Over the past year, QLGN quarterly operating expenses has stayed the same.
- QLGN quarterly operating expenses is now -83.30% below its all-time high of $7.60 million, reached on June 30, 2021.
Performance
QLGN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
QLGN Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -23.4% | 0.0% |
3 y3 years | +5.4% | 0.0% |
5 y5 years | - | 0.0% |
QLGN Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -52.9% | at low | -74.2% | at low |
5 y | 5-year | -52.9% | +5.4% | -83.3% | +165.1% |
alltime | all time | -52.9% | +5.4% | -83.3% | +165.1% |
Qualigen Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $1.27 M(-27.1%) |
Jun 2024 | - | $1.74 M(+22.4%) |
Mar 2024 | - | $1.42 M(-37.5%) |
Dec 2023 | $11.30 M(-23.4%) | $2.27 M(-18.2%) |
Sep 2023 | - | $2.78 M(-22.9%) |
Jun 2023 | - | $3.60 M(+35.9%) |
Mar 2023 | - | $2.65 M(-22.9%) |
Dec 2022 | $14.76 M | $3.44 M(-1.0%) |
Sep 2022 | - | $3.47 M(-22.4%) |
Jun 2022 | - | $4.47 M(-8.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $4.90 M(-0.1%) |
Dec 2021 | $23.98 M(+123.5%) | $4.91 M(-1.2%) |
Sep 2021 | - | $4.97 M(-34.6%) |
Jun 2021 | - | $7.60 M(+16.7%) |
Mar 2021 | - | $6.51 M(+79.2%) |
Dec 2020 | $10.73 M | - |
Sep 2020 | - | $3.63 M(+36.3%) |
Jun 2020 | - | $2.67 M(+457.0%) |
Sep 2019 | - | $478.60 K(-54.8%) |
Jun 2019 | - | $1.06 M |
FAQ
- What is Qualigen Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Qualigen Therapeutics?
- What is Qualigen Therapeutics annual operating expenses year-on-year change?
- What is Qualigen Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly operating expenses year-on-year change?
What is Qualigen Therapeutics annual total operating expenses?
The current annual operating expenses of QLGN is $11.30 M
What is the all time high annual operating expenses for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual total operating expenses is $23.98 M
What is Qualigen Therapeutics annual operating expenses year-on-year change?
Over the past year, QLGN annual total operating expenses has changed by -$3.46 M (-23.41%)
What is Qualigen Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of QLGN is $1.27 M
What is the all time high quarterly operating expenses for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly total operating expenses is $7.60 M
What is Qualigen Therapeutics quarterly operating expenses year-on-year change?
Over the past year, QLGN quarterly total operating expenses has changed by $0.00 (0.00%)